JPWO2022208091A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022208091A5 JPWO2022208091A5 JP2023559999A JP2023559999A JPWO2022208091A5 JP WO2022208091 A5 JPWO2022208091 A5 JP WO2022208091A5 JP 2023559999 A JP2023559999 A JP 2023559999A JP 2023559999 A JP2023559999 A JP 2023559999A JP WO2022208091 A5 JPWO2022208091 A5 JP WO2022208091A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- chain
- clostridial neurotoxin
- polypeptide
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBPCT/GB2021/050783 | 2021-03-30 | ||
| TW110111559A TW202237176A (zh) | 2021-03-30 | 2021-03-30 | 疼痛及發炎性失調之治療 |
| PCT/GB2021/050783 WO2022208039A1 (en) | 2021-03-30 | 2021-03-30 | Catalytically inactive clostridial neurotoxins for the treatment of pain & inflammatory disorders |
| TW110111559 | 2021-03-30 | ||
| PCT/GB2022/050807 WO2022208091A1 (en) | 2021-03-30 | 2022-03-30 | Treatment of pain & inflammatory disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024513191A JP2024513191A (ja) | 2024-03-22 |
| JPWO2022208091A5 true JPWO2022208091A5 (https=) | 2025-04-04 |
| JP2024513191A5 JP2024513191A5 (https=) | 2025-04-04 |
Family
ID=83458127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559999A Pending JP2024513191A (ja) | 2021-03-30 | 2022-03-30 | 疼痛及び炎症性障害の処置 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250195626A1 (https=) |
| EP (1) | EP4313120A1 (https=) |
| JP (1) | JP2024513191A (https=) |
| KR (1) | KR20230163470A (https=) |
| AU (1) | AU2022247196A1 (https=) |
| BR (1) | BR112023020057A2 (https=) |
| CA (1) | CA3213914A1 (https=) |
| WO (1) | WO2022208091A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023089343A1 (en) * | 2021-11-22 | 2023-05-25 | Ipsen Biopharm Limited | Treatment of pain |
| JP2025534349A (ja) * | 2022-09-30 | 2025-10-15 | イプセン バイオファーム リミテッド | 膀胱痛症候群の治療 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| AU3658093A (en) | 1992-02-10 | 1993-09-03 | Seragen, Inc. | Desensitization to specific allergens |
| GB9305735D0 (en) | 1993-03-19 | 1993-05-05 | North John R | Novel agent for controlling cell activity |
| GB9508204D0 (en) | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
| GB9617671D0 (en) | 1996-08-23 | 1996-10-02 | Microbiological Res Authority | Recombinant toxin fragments |
| US7192596B2 (en) | 1996-08-23 | 2007-03-20 | The Health Protection Agency Ipsen Limited | Recombinant toxin fragments |
| GB9721189D0 (en) | 1997-10-08 | 1997-12-03 | Speywood Lab The Limited | Analgesic conjugates |
| DK1084146T3 (da) | 1998-05-13 | 2003-02-03 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Hybridprotein til inhibering af degranuleringen af mastocyter og anvendelse deraf |
| ES2205849T3 (es) | 1998-07-22 | 2004-05-01 | Osprey Pharmaceuticals Limited | Conjugados para tratar alteraciones inflamatorias y asociadas con daños tisulares. |
| GB9818548D0 (en) | 1998-08-25 | 1998-10-21 | Microbiological Res Authority | Treatment of mucas hypersecretion |
| US6776990B2 (en) | 1999-04-08 | 2004-08-17 | Allergan, Inc. | Methods and compositions for the treatment of pancreatitis |
| US6358697B2 (en) | 1999-04-21 | 2002-03-19 | Children's Hospital Medical Center | Intracellular pharmaceutical targeting |
| HK1046020B (en) | 1999-08-25 | 2007-05-11 | Allergan, Inc. | Activatable recombinant neurotoxins |
| GB9922554D0 (en) | 1999-09-23 | 1999-11-24 | Microbiological Res Authority | Inhibition of secretion from non-neuronal cells |
| DE102004043009A1 (de) | 2004-09-06 | 2006-03-23 | Toxogen Gmbh | Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen |
| PL1830872T3 (pl) | 2004-12-01 | 2011-09-30 | Sec Dep For Health | Białka fuzyjne |
| DE102005019302A1 (de) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier zum Targeting von Nervenzellen |
| ES2369558T3 (es) | 2005-09-19 | 2011-12-01 | Allergan, Inc. | Toxinas clostridiales y toxinas clostridiales activables. |
| AU2007272515B2 (en) | 2006-07-11 | 2013-09-26 | Allergan, Inc. | Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells |
| JP2009543558A (ja) | 2006-07-11 | 2009-12-10 | アラーガン、インコーポレイテッド | 増強した転位置能力および増強したターゲティング活性を有する改変クロストリジウム毒素 |
| SG10201606666XA (en) | 2012-05-30 | 2016-09-29 | Harvard College | Engineered Botulinum Neurotoxin |
| GB201312317D0 (en) | 2013-07-09 | 2013-08-21 | Syntaxin Ltd | Cationic neurotoxins |
| CN107108703B (zh) | 2015-01-09 | 2022-09-23 | 益普生生物创新有限公司 | 阳离子神经毒素 |
| PT3274364T (pt) | 2015-03-26 | 2021-11-05 | Harvard College | Neurotoxina botulínica manipulada |
| GB201517450D0 (en) * | 2015-10-02 | 2015-11-18 | Ipsen Biopharm Ltd | Method |
| GB201607901D0 (en) | 2016-05-05 | 2016-06-22 | Ipsen Biopharm Ltd | Chimeric neurotoxins |
| EP3481852B1 (en) | 2016-07-08 | 2022-12-07 | Children's Medical Center Corporation | A novel botulinum neurotoxin and its derivatives |
| UA128185C2 (uk) | 2018-01-29 | 2024-05-01 | Іпсен Біофарм Лімітед | Ботулінічний нейротоксин, який розщеплює ненейронний snare |
| WO2019152380A1 (en) * | 2018-01-30 | 2019-08-08 | Children's Medical Center Corporation | Production of botulinum neurotoxins using bacillus systems |
| GB201815817D0 (en) | 2018-09-28 | 2018-11-14 | Ispen Biopharm Ltd | Clostridial neurotoxins comprising and exogenous activation loop |
| WO2020219358A2 (en) * | 2019-04-17 | 2020-10-29 | Children's Medical Center Corporation | Catalytically inactive botulinum neurotoxin-like toxins and uses thereof |
-
2022
- 2022-03-30 WO PCT/GB2022/050807 patent/WO2022208091A1/en not_active Ceased
- 2022-03-30 US US18/552,788 patent/US20250195626A1/en active Pending
- 2022-03-30 AU AU2022247196A patent/AU2022247196A1/en active Pending
- 2022-03-30 EP EP22716099.1A patent/EP4313120A1/en active Pending
- 2022-03-30 BR BR112023020057A patent/BR112023020057A2/pt unknown
- 2022-03-30 CA CA3213914A patent/CA3213914A1/en active Pending
- 2022-03-30 JP JP2023559999A patent/JP2024513191A/ja active Pending
- 2022-03-30 KR KR1020237036646A patent/KR20230163470A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512899A5 (https=) | ||
| US20220153813A1 (en) | Method for promoting wound healing | |
| JP2007526330A5 (https=) | ||
| CA2367636A1 (en) | Fusion proteins | |
| US10683502B2 (en) | Oligonucleotide decoys for the treatment of pain | |
| JPWO2019157224A5 (https=) | ||
| JP2025060836A5 (https=) | ||
| JP2003532742A (ja) | 神経損傷の修復 | |
| EP3593861B1 (en) | Combination of car peptide and a vasodilator for treating pulmonary hypertension | |
| RU2002130203A (ru) | Пептидные конъюгаты для доставки лекарственного средства | |
| JP2024169509A (ja) | ファーバー病を治療するための組成物及び方法 | |
| AU2017204405B2 (en) | Peptide linkers for polypeptide compositions and methods for using same | |
| Kakoty et al. | Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease | |
| WO2011113024A1 (en) | Compositions and methods for healing of skin wounds | |
| JPWO2022208091A5 (https=) | ||
| JP2020508984A5 (https=) | ||
| DE602004001509T2 (de) | Verwendung von hsp20 zur förderung der wundheilung und / oder zur reduzierung von narbenbildung | |
| US10160791B2 (en) | Protamine in treatment of neuronal injuries | |
| RU2023127652A (ru) | Каталитически неактивные клостридиальные нейротоксины для лечения боли и воспалительных заболеваний | |
| JP2005508875A5 (https=) | ||
| KR20220151004A (ko) | 새로운 재생 치료제로서의 camkk1 | |
| CN120818018A (zh) | Fga来源12肽在制备神经损伤修复药物中的用途 | |
| de Castro et al. | Regulation of Oligodendrocyte Differentiation: New Targets for Drug | |
| WO2025006508A2 (en) | Compositions and methods for reducing pain and inflammation through epigenetic modulation | |
| Class et al. | Patent application title: PROTAMINE IN TREATMENT OF NEURONAL INJURIES |